For instance, findings from the analysis of 30 advanced CRC cases by COX-2 mRNA quantitative PCR, showed that COX-2 mRNA is higher in low-grade CRC (WDA and MDA; 93%) compared to PDA (7%) [51]. This evidence concerns the gene PTGS2 and Patent ductus arteriosus.